Indian Journal of Urology Users online:894  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Differential Expression of Matrix Metalloproteinase-2 Expression in Disseminated Tumor Cells and Micrometastasis in Bone Marrow of Patients with Nonmetastatic and Metastatic Prostate Cancer: Theoretical Considerations and Clinical Implications—An Immunocytochemical Study
Nigel P. Murray,Eduardo Reyes,Pablo Tapia,Leonardo Badínez,Nelson Orellana
Bone Marrow Research.2012;2012()1
[DOI]
2Comparison of the Walz Nomogram and Presence of Secondary Circulating Prostate Cells for Predicting Early Biochemical Failure after Radical Prostatectomy for Prostate Cancer in Chilean Men
Nigel P Murray,Eduardo Reyes,Nelson Orellana,Cynthia Fuentealba,Omar Jacob
Asian Pacific Journal of Cancer Prevention.2015;16(16)7123
[DOI]
3Cellules tumorales circulantes et cancer de la prostate avancé
Thibaut Murez,Stéphane Droupy,Xavier Rebillard,Catherine Alix-Panabieres
Bulletin du Cancer.2012;99(1)S4
[DOI]
4Possible Role of HER-2 in the Progression of Prostate Cancer from Primary Tumor to Androgen Independence
Nigel P Murray,Eduardo Reyes,Cynthia Fuentealba,Omar Jacob,Nelson Orellana
Asian Pacific Journal of Cancer Prevention.2015;16(15)6615
[DOI]
5Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management
Nigel P. Murray
Biological Research.2018;51(1)6615
[DOI]
6Biomarkers in Prostate Cancer Epidemiology
Mukesh Verma,Payal Patel,Mudit Verma
Cancers.2011;3(4)3773
[DOI]
7Effect of Androgen Blockade on HER-2 and Matrix Metalloproteinase-2 Expression on Bone Marrow Micrometastasis and Stromal Cells in Men with Prostate Cancer
N. P. Murray,E. Reyes,L. Badinez,N. Orellana,C. Fuentealba,R. Olivares,J. Porcell,R. Dueñas
The Scientific World Journal.2013;2013(4)1
[DOI]
8Prediction model for early biochemical recurrence after radical prostatectomy based on the Cancer of the Prostate Risk Assessment score and the presence of secondary circulating prostate cells
Nigel P. Murray,Socrates Aedo,Eduardo Reyes,Nelson Orellana,Cynthia Fuentealba,Omar Jacob
BJU International.2016;118(4)556
[DOI]
9Redefining micrometastasis in prostate cancer - a comparison of circulating prostate cells, bone marrow disseminated tumor cells and micrometastasis: Implications in determining local or systemic treatment for biochemical failure after radical prostatectomy
N.P. MURRAY,E. REYES,P. TAPIA,L. BADINEZ,N. ORELLANA,C. FUENTEALBA,R. OLIVARES,J. PORCELL,R. DUEÑAS
International Journal of Molecular Medicine.2012;30(4)896
[DOI]
10Biomarkers detecting minimal residual disease in solid tumors: what do they mean in the clinical management of patients?
Nigel P Murray
Biomarkers in Medicine.2019;13(18)1535
[DOI]
  Search 
  The Journal 
  The Association 
  Site Statistics 
  Addresses 
  e-Alerts 
  Online Submission 

Submit Articles

Alerts

Join us

HEALTHWARE INDIA